227 related articles for article (PubMed ID: 25149474)
1. Prostate cancer risk locus at 8q24 as a regulatory hub by physical interactions with multiple genomic loci across the genome.
Du M; Yuan T; Schilter KF; Dittmar RL; Mackinnon A; Huang X; Tschannen M; Worthey E; Jacob H; Xia S; Gao J; Tillmans L; Lu Y; Liu P; Thibodeau SN; Wang L
Hum Mol Genet; 2015 Jan; 24(1):154-66. PubMed ID: 25149474
[TBL] [Abstract][Full Text] [Related]
2. A functional variant at a prostate cancer predisposition locus at 8q24 is associated with PVT1 expression.
Meyer KB; Maia AT; O'Reilly M; Ghoussaini M; Prathalingam R; Porter-Gill P; Ambs S; Prokunina-Olsson L; Carroll J; Ponder BA
PLoS Genet; 2011 Jul; 7(7):e1002165. PubMed ID: 21814516
[TBL] [Abstract][Full Text] [Related]
3. Chromatin interactions and candidate genes at ten prostate cancer risk loci.
Du M; Tillmans L; Gao J; Gao P; Yuan T; Dittmar RL; Song W; Yang Y; Sahr N; Wang T; Wei GH; Thibodeau SN; Wang L
Sci Rep; 2016 Mar; 6():23202. PubMed ID: 26979803
[TBL] [Abstract][Full Text] [Related]
4. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
[TBL] [Abstract][Full Text] [Related]
5. 4C-seq revealed long-range interactions of a functional enhancer at the 8q24 prostate cancer risk locus.
Cai M; Kim S; Wang K; Farnham PJ; Coetzee GA; Lu W
Sci Rep; 2016 Mar; 6():22462. PubMed ID: 26934861
[TBL] [Abstract][Full Text] [Related]
6. 3C-digital PCR for quantification of chromatin interactions.
Du M; Wang L
BMC Mol Biol; 2016 Dec; 17(1):23. PubMed ID: 27923366
[TBL] [Abstract][Full Text] [Related]
7. 8q24 and prostate cancer: association with advanced disease and meta-analysis.
Cheng I; Plummer SJ; Jorgenson E; Liu X; Rybicki BA; Casey G; Witte JS
Eur J Hum Genet; 2008 Apr; 16(4):496-505. PubMed ID: 18231127
[TBL] [Abstract][Full Text] [Related]
8. A rare variant of African ancestry activates 8q24 lncRNA hub by modulating cancer associated enhancer.
Walavalkar K; Saravanan B; Singh AK; Jayani RS; Nair A; Farooq U; Islam Z; Soota D; Mann R; Shivaprasad PV; Freedman ML; Sabarinathan R; Haiman CA; Notani D
Nat Commun; 2020 Jul; 11(1):3598. PubMed ID: 32680982
[TBL] [Abstract][Full Text] [Related]
9. Statistical recombinant mapping in extended high-risk Utah pedigrees narrows the 8q24 prostate cancer locus to 2.0 Mb.
Camp NJ; Farnham JM; Allen-Brady K; Cannon-Albright LA
Prostate; 2007 Sep; 67(13):1456-64. PubMed ID: 17654497
[TBL] [Abstract][Full Text] [Related]
10. Multiple loci with different cancer specificities within the 8q24 gene desert.
Ghoussaini M; Song H; Koessler T; Al Olama AA; Kote-Jarai Z; Driver KE; Pooley KA; Ramus SJ; Kjaer SK; Hogdall E; DiCioccio RA; Whittemore AS; Gayther SA; Giles GG; Guy M; Edwards SM; Morrison J; Donovan JL; Hamdy FC; Dearnaley DP; Ardern-Jones AT; Hall AL; O'Brien LT; Gehr-Swain BN; Wilkinson RA; Brown PM; Hopper JL; Neal DE; Pharoah PD; Ponder BA; Eeles RA; Easton DF; Dunning AM; ;
J Natl Cancer Inst; 2008 Jul; 100(13):962-6. PubMed ID: 18577746
[TBL] [Abstract][Full Text] [Related]
11. Germline variation at 8q24 and prostate cancer risk in men of European ancestry.
Matejcic M; Saunders EJ; Dadaev T; Brook MN; Wang K; Sheng X; Olama AAA; Schumacher FR; Ingles SA; Govindasami K; Benlloch S; Berndt SI; Albanes D; Koutros S; Muir K; Stevens VL; Gapstur SM; Tangen CM; Batra J; Clements J; Gronberg H; Pashayan N; Schleutker J; Wolk A; West C; Mucci L; Kraft P; Cancel-Tassin G; Sorensen KD; Maehle L; Grindedal EM; Strom SS; Neal DE; Hamdy FC; Donovan JL; Travis RC; Hamilton RJ; Rosenstein B; Lu YJ; Giles GG; Kibel AS; Vega A; Bensen JT; Kogevinas M; Penney KL; Park JY; Stanford JL; Cybulski C; Nordestgaard BG; Brenner H; Maier C; Kim J; Teixeira MR; Neuhausen SL; De Ruyck K; Razack A; Newcomb LF; Lessel D; Kaneva R; Usmani N; Claessens F; Townsend PA; Gago-Dominguez M; Roobol MJ; Menegaux F; Khaw KT; Cannon-Albright LA; Pandha H; Thibodeau SN; Schaid DJ; ; Wiklund F; Chanock SJ; Easton DF; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
Nat Commun; 2018 Nov; 9(1):4616. PubMed ID: 30397198
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the 8q24 prostate cancer risk locus and MYC expression.
Pomerantz MM; Beckwith CA; Regan MM; Wyman SK; Petrovics G; Chen Y; Hawksworth DJ; Schumacher FR; Mucci L; Penney KL; Stampfer MJ; Chan JA; Ardlie KG; Fritz BR; Parkin RK; Lin DW; Dyke M; Herman P; Lee S; Oh WK; Kantoff PW; Tewari M; McLeod DG; Srivastava S; Freedman ML
Cancer Res; 2009 Jul; 69(13):5568-74. PubMed ID: 19549893
[TBL] [Abstract][Full Text] [Related]
13. An 8q24 gene desert variant associated with prostate cancer risk confers differential in vivo activity to a MYC enhancer.
Wasserman NF; Aneas I; Nobrega MA
Genome Res; 2010 Sep; 20(9):1191-7. PubMed ID: 20627891
[TBL] [Abstract][Full Text] [Related]
14. Association of a novel long non-coding RNA in 8q24 with prostate cancer susceptibility.
Chung S; Nakagawa H; Uemura M; Piao L; Ashikawa K; Hosono N; Takata R; Akamatsu S; Kawaguchi T; Morizono T; Tsunoda T; Daigo Y; Matsuda K; Kamatani N; Nakamura Y; Kubo M
Cancer Sci; 2011 Jan; 102(1):245-52. PubMed ID: 20874843
[TBL] [Abstract][Full Text] [Related]
15. Confirmation study of prostate cancer risk variants at 8q24 in African Americans identifies a novel risk locus.
Robbins C; Torres JB; Hooker S; Bonilla C; Hernandez W; Candreva A; Ahaghotu C; Kittles R; Carpten J
Genome Res; 2007 Dec; 17(12):1717-22. PubMed ID: 17978284
[TBL] [Abstract][Full Text] [Related]
16. 8q24 genetic variation and comprehensive haplotypes altering familial risk of prostate cancer.
Dupont WD; Breyer JP; Plummer WD; Chang SS; Cookson MS; Smith JA; ; Blue EE; Bamshad MJ; Smith JR
Nat Commun; 2020 Mar; 11(1):1523. PubMed ID: 32251286
[TBL] [Abstract][Full Text] [Related]
17. 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC.
Ahmadiyeh N; Pomerantz MM; Grisanzio C; Herman P; Jia L; Almendro V; He HH; Brown M; Liu XS; Davis M; Caswell JL; Beckwith CA; Hills A; Macconaill L; Coetzee GA; Regan MM; Freedman ML
Proc Natl Acad Sci U S A; 2010 May; 107(21):9742-6. PubMed ID: 20453196
[TBL] [Abstract][Full Text] [Related]
18. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C.
Dryden NH; Broome LR; Dudbridge F; Johnson N; Orr N; Schoenfelder S; Nagano T; Andrews S; Wingett S; Kozarewa I; Assiotis I; Fenwick K; Maguire SL; Campbell J; Natrajan R; Lambros M; Perrakis E; Ashworth A; Fraser P; Fletcher O
Genome Res; 2014 Nov; 24(11):1854-68. PubMed ID: 25122612
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-1205, encoded on chromosome 8q24, targets EGLN3 to induce cell growth and contributes to risk of castration-resistant prostate cancer.
Wang Y; Li X; Liu W; Li B; Chen D; Hu F; Wang L; Liu XM; Cui R; Liu R
Oncogene; 2019 Jun; 38(24):4820-4834. PubMed ID: 30808975
[TBL] [Abstract][Full Text] [Related]
20. Pesticide use modifies the association between genetic variants on chromosome 8q24 and prostate cancer.
Koutros S; Beane Freeman LE; Berndt SI; Andreotti G; Lubin JH; Sandler DP; Hoppin JA; Yu K; Li Q; Burdette LA; Yuenger J; Yeager M; Alavanja MC
Cancer Res; 2010 Nov; 70(22):9224-33. PubMed ID: 20978189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
